Abstract
Despite important inroads into the molecular pathology of Alzheimer disease, effective long-term treatment for the condition remains elusive. Among the many gene products that are recognized as factors in the disease is apolipoprotein ( (apoE). The risk that specific isoforms of apoE pose with regard to Alzheimer Disease clearly varies, and so the roles that apoE plays in the brain will be crucial to a full understanding of the disease and to efforts to develop effective therapies.
Original language | English |
---|---|
Pages (from-to) | 363-375, 339 |
Journal | Molecular interventions |
Volume | 2 |
Issue number | 6 |
DOIs | |
State | Published - Oct 2002 |